Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Balding men have harder scalps.

Botryococcus terribilis Ethanol Extract may reduce inflammation by changing gene expression in cells.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Increased FGFR2b signaling, influenced by androgens, plays a role in causing acne.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Cilostazol helps hair grow by making hair root cells grow faster and changing growth factor levels.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

EGFR and mTOR inhibitors may help manage Olmsted syndrome symptoms.

The TRPV3 ion channel is important for skin and hair health and could be a target for treating skin conditions.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

The conclusion is that Fgf18 and Tgf-ß signaling could be targeted for hair loss treatments.

Intermittent isotretinoin can cause various skin, hair, and nail changes.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

PRIDE syndrome includes skin and hair issues from cancer treatment with EGFR inhibitors.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.